GLPwatch
Trials (2167)
Page 29 of 37.
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
- A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
- Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
- The Effect of Semaglutide on Bone Health
- Incretin Therapies in Obesity-related HFpEF
- Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
- Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
- Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
- Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy
- Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
- Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
- STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
- A Study of LY3502970 in Participants With Type 2 Diabetes
- Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
- IBI3042 Study in Healthy Participants and Overweight or Obese Participants
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
- Prevention of Progression of Prediabetes, Obesity and CV Risk
- Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
- Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
- Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
- Physical and Chemical Study of Atherosclerosis Mechanisms
- Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
- GLP1R-imaging in Hypoglycemia
- Semaglutide in CFRD
- This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
- A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
- Young Adults With Early-onset Obesity Treated With Semaglutide
- Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
- Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
- A Study of LY3502970 in Healthy Participants
- A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
- Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
- The Lira Pump Trial
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
- Exenatide for Stress Hyperglycemia
- A Study of LY3841136 in Japanese Participants With Obesity or Overweight
- Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
- Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
- The POST-ACS Study
- A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
- Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways)
- A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
- Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
- Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
- The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
- Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
- Brain Activation and Satiety in Children 2
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
- Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
- Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
- Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
- Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention